Effects of single-dose methylphenidate on cognitive performance in patients with traumatic brain injury: A double-blind placebo-controlled study

Clinical Rehabilitation

Volumn 20, Issue 1, 2006, Pages 24-30

  Kim, Yun Hee ^a   Ko, Myoung Hwan ^b   Na, Seung Yong ^b   Park, Se Hun ^a   Kim, Kee Won ^b  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Chonbuk National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPHENIDATE; PLACEBO;

ADULT; ALERTNESS; ARTICLE; ATTENTION; BRAIN INJURY; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITIVE DEFECT; COMPUTER PROGRAM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; HUMAN; MALE; RANDOMIZED CONTROLLED TRIAL; REACTION TIME; SINGLE DRUG DOSE; TASK PERFORMANCE; TREATMENT OUTCOME; TREATMENT RESPONSE; WORKING MEMORY;

ADULT; ATTENTION; BRAIN INJURIES; CENTRAL NERVOUS SYSTEM STIMULANTS; COGNITION; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MEMORY; METHYLPHENIDATE; REACTION TIME; STATISTICS, NONPARAMETRIC;

EID: 32644482161     PISSN: 02692155     EISSN: None     Source Type: Journal    
DOI: 10.1191/0269215506cr927oa     Document Type: Article

References (30)

1. Bontke CF, Boake C. Principles of brain injury rehabilitation. In Braddom RL ed. Physical medicine and rehabilitation, first edition. Saunders, 1996: 1027-51.
2. Kaelin DL, Cifu DX, Matthies B. Methylphenidate effect on attention deficit in the acutely brain-injured adult. Am J Phys Med Rehabil 1996; 77: 6-9.
3. Plenger PM, Dixon CE, Castillo RM et al. Subacute methylphenidate treatment for moderate to moderately severe traumatic brain injury: a preliminary double-blind placebo-controlled study. Am J Phys Med Rehabil 1996; 77: 536-40.
4. Hornyark JE, Nelson VS, Hurvitz EA. The use of methylphenidate in paediatric traumatic brain injury. Pediatr Rehabil 1997; 1: 15-17.
5. Meyers CA, Weitzner MA, Valentine AD et al. Methylphenidate therapy improves cognition, mood, and function of brain tumor patients. J Clin Oncol 1998; 16: 2522-27.
6. Whyte J, Vaccaro M, Grieb-Neff P, Hart T. Psychostimulant use in the rehabilitation of individuals with traumatic brain injury. J Head Trauma Rehabil 2002; 17: 284-99.
7. Patrick PD, Buck ML, Conaway MR et al. The use of dopamine enhancing medications with children in low response states following brain injury. Brain Inj 2003; 17: 497-506.
8. Galynker I, Ieronimo C, Miner C et al. Methylphenidate treatment of negative symptoms in patients with dementia. J Neuropsychiat Clin Neurosci 1997; 9: 231-39.
9. Grade C, Redford B, Chrostowski J et al. Methylphenidate in early poststroke recovery: a double-blind, placebo-controlled study. Am J Phys Med Rehabil 1998; 79: 1047-50.
10. Sekine Y, Iyo M, Tanaka K et al. Effective adjunctive use of low-dose methylphenidate with mianserin for major depression with silent cerebral infarction: a case report. J Clin Psychopharmacol 2001; 20: 584-85.
11. Goldstein LB. Amphetamines and related drugs in motor recovery after stroke. Phys Med Rehabil Clin N Am 2003; 14: 125-34.
12. Elliott R, Sahakian BJ, Matthews K et al. Effects of methylphenidate on spatial working memory and planning in healthy young adults. Psychopharmacology (Berl) 1997; 131: 196-206.
13. Kevin SL, Darren RG, Parrish TB et al. Neuroanatomic overlap of working memory and spatial attention networks: a functional MRI comparison within subjects. Neuroimage 1999; 10: 695-704.
14. Posner MI. Orientation of attention. Q J Exp Psychol 1980; 32: 3-25.
15. Kim Y-H, Gitelman DR, Nobre AC et al. The large-scale network for spatial attention dispalys multifunctional overlap but differential asymmetry. Neuroimage 1999; 9: 269-77.
16. Wax P. Analeptic use in clinical toxicology: a historical appraisal. Clin Toxicol 1997; 35: 203-209.
17. Gilman AG, Goodman LS, Rall TW, Murad F. Neurohumoral transmission and the central nervous system. In Gilman AG, Goodman LS eds. The pharmacological basis of therapeutics. Macmillan, 1985: 236-59.
18. Johnson ML, Roberts MD, Ross AR. Methylphenidate in stroke patients with depression. Am J Phys Med Rehabil 1992; 71: 239-42.
19. Speech TJ, Rao SM, Osmon DC et al. A double-blind controlled study of methylphenidate treatment in closed head injury. Brain Inj 1993; 7: 333-38.
20. Gualtieri CT, Evans RW. Stimulant treatment for the neurobehavioral sequelae of traumatic brain injury. Brain Inj 1988; 2: 273-90.
21. McFadyen MP, Brown RE, Carry N. Subchronic methylphenidate administration has no effect on locomotion, emotional behavior, or water maze learning in prepubertal mice. Dev Psychobiol 2002; 41: 123-32.
22. Kline AE, Yan HQ, Bao J et al. Chronic methylphenidate treatment enhances water maze performance following traumatic brain injury in rats. Neurosci Lett 2000; 280: 163-66.
23. Sawaguchi T, Goldman-Rakic PS. The role of D1-dopamine receptor in working memory: local injections of dopamine antagonists into the prefrontal cortex of rhesus monkeys performing an oculomotor delayed-response task. J Neurophysiol 1994; 71: 515-28.
24. Mehta M, Owen A, Sahakian B et al. Methylphenidate enhances working memory by modulating discrete frontal and parietal lobe regions in the human brain. J Neurosci 2000; 20: 1-6.
25. Szobot CM, Ketzer C, Cunha RD et al. The acute effect of methylphenidate on cerebral blood flow in boys with attention-deficit/hyperactivity disorder. Eur J Nucl Med Mol Imaging 2003; 30: 423-26.
26. Ilic TV, Korchounov A, Ziemann U. Methylphenidate facilitates and disinhibits the motor cortex in intact humans. Neuroreport 2003; 15: 773-76.
27. Lazarus LW, Winemiller DR, Lingaam VR. Efficacy and side effect of methylphenidate for stroke depression. J Clin Psychiatry 1992; 53: 447-49.
28. Burke DT, Glenn MB, Vesali F et al. Effects of methylphenidate on heart rate and blood pressure among inpatients with acquired brain injury. Am J Phys Med Rehabil 2003; 82: 493-97.
29. Wroblewski BA, Leary JM, Phelan AM et al. Methylphenidate and seizure frequency in brain injured patients with seizure disorders. J Clin Psychiatry 1992; 53: 86-89.
30. Moore JL, McAuley JW, Long L et al. An evaluation of the effects of methylphenidate on outcomes in adult epilepsy patients. Epilepsy Behav 2002; 3: 92-95.